September 1, 2026 Atezolizumab in Early-Stage Triple-Negative Breast Cancer: NSABP B-59/GeparDouze Trial Results and Biomarker Analysis
June 26, 2026 Encouraging Clinical Responses in Early-Stage Breast Cancer with Immune-Modulating Radiation Therapy
February 19, 2026 Phase 1 Trial of Personalized mRNA Vaccine for Advanced Breast Cancer: Safety, Immunity & Long-Term Outcomes